Major clinical features of 3 patients with immunodeficiency and immune dysregulation
. | P1 . | P2 . | P3 . |
---|---|---|---|
Immunodeficiency | |||
Recurrent respiratory tract infections | ++ | + | ++ |
Bronchiectasis | ++ | + | ++ |
Herpes viral infection | ++ | + | + |
Lymphoproliferation | |||
Lymphadenopathy | + | + | + |
Hepatosplenomegaly | + | + | + |
Lymphoma | + | + | + |
Autoimmunity | |||
Autoimmune cytopenias | + | + | − |
Autoantibodies | + | + | − |
Laboratory values | |||
Class-switched memory B cells | ↓ | ↓ | ↓ |
FasL-mediated apoptosis | ↓ | ↓ | Normal |
Soluble FasL | ↑ | ↑ | Normal |
DNTs | ↑ | ↑/Normal | ↑ |
Specific antibodies | Normal | ND | ↓ |
Developmental delay | |||
Moderate | + | + | + |
Outcome of HSCT | |||
Autologous T-cell reconstitution | + | + | + |
Split mixed chimerism | Rejected and died | Rejected and died |
. | P1 . | P2 . | P3 . |
---|---|---|---|
Immunodeficiency | |||
Recurrent respiratory tract infections | ++ | + | ++ |
Bronchiectasis | ++ | + | ++ |
Herpes viral infection | ++ | + | + |
Lymphoproliferation | |||
Lymphadenopathy | + | + | + |
Hepatosplenomegaly | + | + | + |
Lymphoma | + | + | + |
Autoimmunity | |||
Autoimmune cytopenias | + | + | − |
Autoantibodies | + | + | − |
Laboratory values | |||
Class-switched memory B cells | ↓ | ↓ | ↓ |
FasL-mediated apoptosis | ↓ | ↓ | Normal |
Soluble FasL | ↑ | ↑ | Normal |
DNTs | ↑ | ↑/Normal | ↑ |
Specific antibodies | Normal | ND | ↓ |
Developmental delay | |||
Moderate | + | + | + |
Outcome of HSCT | |||
Autologous T-cell reconstitution | + | + | + |
Split mixed chimerism | Rejected and died | Rejected and died |
+, feature present; ++, major feature; −, feature absent; ↓, lower than normal; ↑, higher than normal; ND, not determined.